- Home
- CURI vs DERM Comparison
CURI vs DERM Comparison
Compare CURI & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURI | DERM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.8M | 213.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CURI | DERM |
|---|---|---|
| Price | $4.62 | $7.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.00 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 805.8K | 155.0K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | ★ 6.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $66,595,000.00 | $59,399,000.00 |
| Revenue This Year | $42.19 | $18.34 |
| Revenue Next Year | $7.55 | $54.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.62 | 2.82 |
| 52 Week Low | $1.47 | $3.54 |
| 52 Week High | $7.15 | $9.40 |
Technical Indicators
Market Signals| Indicator | CURI | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 50.58 | 46.80 |
| Support Level | $4.42 | $7.52 |
| Resistance Level | $5.00 | $8.53 |
| Average True Range (ATR) | 0.23 | 0.42 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 34.48 | 34.92 |
Price Performance
Historical ComparisonAbout CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.